Establishment Labs Holdings Inc
NASDAQ:ESTA
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
CR |
Establishment Labs Holdings Inc
NASDAQ:ESTA
|
1.6B USD | 10 | ||
CH |
Alcon AG
SIX:ALC
|
39.5B CHF | 4.6 | ||
JP |
Hoya Corp
TSE:7741
|
6.6T JPY | 8.8 | ||
DK |
Coloplast A/S
CSE:COLO B
|
191.9B DKK | 7.7 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
20.4B USD | 5.2 | ||
US |
Cooper Companies Inc
NYSE:COO
|
19.3B USD | 5.3 | ||
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
58.3B CNY | 14.3 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.2B GBP | 3.1 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.7T KRW | 203.1 | |
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.9B USD | 1.5 | ||
US |
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.5B USD | 4 |
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.